Are renoprotection guidelines followed in elderly patients with diabetes?
Rebecca Ireland
This article has no abstract so we have provided the first paragraph of the full text.
US guidelines recommend that diabetic patients with nephropathy, hypertension, or both, use angiotension-converting-enzyme (ACE) inhibitors or angiotension-II receptor blockers (ARBs) to help slow progression of chronic kidney disease. Winkelmayer et al. used Medicare data to explore application of these guidelines to treatment of elderly diabetic patients (
65 years) who were eligible to receive comprehensive drug treatment from the state of Pennsylvania in 2002. Patients with end-stage renal disease were excluded from the analysis.
Full text of this article is available with one of the following:
- Membership of the International Society of Nephrology. If already a member, please login. If not please join the Society now
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please login for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or login above.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
